ATM and ovarian cancer: Recently published studies assessing the clinical validity of genes frequently tested in hereditary breast and ovarian cancer mostly agree that ATM, BRCA1, BRCA2, CHEK2, and PALB2 are strongly associated with a risk of breast cancer (overall with a p value of less than 0.0001) [43,44,45].